Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+55.5%
5Y CAGR+35.7%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+55.5%/yr
Annual compound
5Y CAGR
+35.7%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
4.6x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 267.09% |
| 2024 | -74.02% |
| 2023 | 68.08% |
| 2022 | 71.04% |
| 2021 | -128.56% |
| 2020 | 58.08% |
| 2019 | -166.49% |
| 2018 | -71.51% |
| 2017 | -204.59% |
| 2016 | 204.59% |